---
title: "Ocugen Inc. Stock Rises Thursday, Outperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284839744.md"
description: "Shares of Ocugen Inc. (OCGN) rose 2.98% to $1.73 on Thursday, outperforming the market as the S&P 500 and Dow Jones also saw gains. This marks the second consecutive day of increases for Ocugen, although it remains 36.51% below its 52-week high of $2.73 reached on March 17. Trading volume was 4.0 million, significantly below the 50-day average of 8.9 million."
datetime: "2026-04-30T21:27:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284839744.md)
  - [en](https://longbridge.com/en/news/284839744.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284839744.md)
---

# Ocugen Inc. Stock Rises Thursday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) advanced 2.98% to $1.73 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.02% to 7,209.01 and the Dow Jones Industrial Average rising 1.62% to 49,652.14.

This was the stock's second consecutive day of gains.

Ocugen Inc. closed 36.51% short of its 52-week high of $2.73, which the company achieved on March 17th.

Trading volume (4.0 M) remained 4.8 million below its 50-day average volume of 8.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 30, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

04-30-26 1727ET

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [BUZZ-Ocugen plunges after $115 million convertible bonds offering, bigger loss](https://longbridge.com/en/news/285252501.md)
- [Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway](https://longbridge.com/en/news/285244765.md)
- [Gene therapy firm Ocugen's Q1 revenue beats, extends cash runway to 2028](https://longbridge.com/en/news/285208944.md)
- [Ernexa Therapeutics Stock Climbs On Breakthrough Preclinical Data](https://longbridge.com/en/news/285400985.md)
- [Bioventus Q1 revenue rises 7%, beats expectations](https://longbridge.com/en/news/285369073.md)